ST13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.332800E-01
Normal-vs-Stage2
7.211200E-01
Normal-vs-Stage3
1.895560E-01
Normal-vs-Stage4
8.663600E-01
Stage1-vs-Stage2
1.733600E-01
Stage1-vs-Stage3
3.180300E-02
Stage1-vs-Stage4
7.474200E-01
Stage2-vs-Stage3
3.000400E-01
Stage2-vs-Stage4
4.864400E-01
Stage3-vs-Stage4
2.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.540600E-01
Normal-vs-AfricanAmerican
5.049800E-01
Normal-vs-Asian
4.229200E-01
Caucasian-vs-AfricanAmerican
2.456400E-01
Caucasian-vs-Asian
2.862600E-01
AfricanAmerican-vs-Asian
8.048200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.396200E-01
Normal-vs-Female
8.926800E-01
Male-vs-Female
6.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.795400E-01
Normal-vs-Age(41-60Yrs)
7.087600E-01
Normal-vs-Age(61-80Yrs)
7.210600E-01
Normal-vs-Age(81-100Yrs)
4.477400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.883400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.408200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.215600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.241400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.024400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.390000E-01
Normal-vs-Daily Drinker
2.614000E-01
Normal-vs-Weekly Drinker
5.276000E-01
Normal-vs-Occasional Drinker
5.594800E-01
Normal-vs-Social Drinker
9.762800E-01
Non Drinker-vs-Daily Drinker
4.195400E-01
Non Drinker-vs-Weekly Drinker
7.298200E-01
Non Drinker-vs-Occasional Drinker
3.335700E-03
Non Drinker-vs-Social Drinker
1.982250E-01
Daily Drinker-vs-Weekly Drinker
3.690400E-01
Daily Drinker-vs-Occasional Drinker
2.279800E-03
Daily Drinker-vs-Social Drinker
7.208200E-02
Weekly Drinker-vs-Occasional Drinker
4.528500E-02
Weekly Drinker-vs-Social Drinker
3.616800E-01
Occasional Drinker-vs-Social Drinker
4.089800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.278400E-01
Normal-vs-Grade 2
7.865400E-01
Normal-vs-Grade 3
7.863200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.948600E-01
Grade 1-vs-Grade 3
7.154400E-01
Grade 1-vs-Grade 4
5.278400E-01
Grade 2-vs-Grade 3
9.909000E-01
Grade 2-vs-Grade 4
7.865400E-01
Grade 3-vs-Grade 4
7.863200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.137000E-01
Normal-vs-NonDiabetic
8.581200E-01
Diabetic-vs-NonDiabetic
3.904000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.905600E-01
Normal-vs-NoPancreatitis
8.353800E-01
Pancreatitis-vs-NoPancreatitis
8.926000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.949200E-01
Normal-vs-N1
7.587400E-01
N0-vs-N1
4.356400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.846800E-01
Normal-vs-TP53-NonMutant
9.964000E-01
TP53-Mutant-vs-TP53-NonMutant
6.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
